LPA and Stroke: In contrast, genetically determined low Lp(a) concentrations have been associated with a decreased risk of coronary heart disease (CHD), PAD, stroke, HF, and AVS [19]; at the same time it appears that genetically determined low Lp(a) concentrations do not cause any significant increase in the risks of other disorders, including diabetes and cancer [19].